Not available
Quote | Ophthotech Corporation (NASDAQ:OPHT)
Last: | $ |
---|---|
Change Percent: | -0.71% |
Open: | $1.44 |
Close: | $1.39 |
High: | $1.48 |
Low: | $1.39 |
Volume: | 303,384 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Ophthotech Corporation (NASDAQ:OPHT)
As part the transition strategy to developing gene therapy solutions for orphan inherited retinal diseases, Ophthotech (NASDAQ: OPHT ) is changing its name to IVERIC bio. More news on: Ophthotech Corporation, Healthcare stocks news, Read more ...
- Company’s Shares Will Trade Under New Ticker Symbol: ISEE – Ophthotech Corporation (Nasdaq:OPHT) today announced that as part of its transition strategy to focus on discovering and developing novel gene therapy solutions to treat orphan inherited retinal diseases (IR...
Message Board Posts | Ophthotech Corporation (NASDAQ:OPHT)
Subject | By | Source | When |
---|---|---|---|
ADX and PPO lines pinching beautifully and just | PennyStock Alert | investorshub | 01/13/2019 12:52:00 AM |
https://www.stocknewsjournal.com/2017/11/23/revenue-approximations-analysis-opht | PennyStock Alert | investorshub | 01/13/2019 12:51:35 AM |
Definitely oversold:) | PennyStock Alert | investorshub | 01/13/2019 12:51:03 AM |
Reversal confirmed? | PennyStock Alert | investorshub | 01/13/2019 12:50:45 AM |
Somethings brewing in here again. Volume picking up. | Klinsmann | investorshub | 01/08/2019 8:47:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Ophthotech Corporation Company Name:
OPHT Stock Symbol:
NASDAQ Market:
Ophthotech Corporation Website:
- Company’s Shares Will Trade Under New Ticker Symbol: ISEE – Ophthotech Corporation (Nasdaq:OPHT) today announced that as part of its transition strategy to focus on discovering and developing novel gene therapy solutions to treat orphan inherited retinal diseases (IR...
Ophthotech Corporation (NASDAQ: OPHT) announced today that the Company has converted its option and entered into an exclusive global license agreement with the University of Pennsylvania (Penn), including the Perelman School of Medicine at the University of Pennsylvania and the University ...
Ophthotech Corporation (Nasdaq: OPHT) announced today that Kourous A. Rezaei, M.D., Chief Medical Officer, will present an overview of the Company at the Alliance for Regenerative Medicine’s (ARM) 7 th Annual Cell and Gene Therapy Investor Day in New York, NY, on Thursday, March 21...